Skip to content
ISBN: 6138395395
ISBN13: 9786138395393

Nanoformulation Containing an Exosome-Derived Monoclonal Antibody

$82.65List Price: $87.00
Save $4.35!
ISBN: 6138395395
ISBN13: 9786138395393
Formats

Conditions

A brand-new, unused copy in perfect condition.

Formats

Conditions

A brand-new, unused copy in perfect condition.

See all 1 editionsfrom $82.65

Book Overview

The book introduces an innovative approach to overcoming therapeutic resistance in one of the most aggressive brain cancers. This book explores how nanotechnology, exosome engineering, and targeted delivery systems can be combined to improve drug transport across the blood-brain barrier. It emphasizes the role of exosome-derived monoclonal antibodies and TfR-targeting ligands in enhancing specificity, stability, and therapeutic efficacy for glioblastoma treatment. The text integrates concepts from molecular biology, oncology, pharmacology, and bioengineering, providing a multidisciplinary perspective on translational applications. With a focus on precision medicine, the book outlines preclinical insights, potential clinical strategies, and future directions for nanoformulated therapies that bridge diagnostics and therapeutics. It serves as a valuable resource for researchers, clinicians, and graduate students seeking to advance glioblastoma treatment through cutting-edge nanomedicine platforms.
Format:
Paperback
Language:
English
ISBN:
6138395395
ISBN13:
9786138395393
Release Date:
October 2025
Publisher:
Scholars' Press
Length:
144 Pages
Weight:
0.44 lbs.
Dimensions:
0.3″ × 6.0″ × 9.0″
MedicalMedical Books

More by Fatemeh Kabiri

Customer Reviews

0 customer ratings | 0 reviews
Write a Review

There are currently no reviews. Be the first to review this work.